INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco receives USFDA approval for Succinylcholine Chloride Injection USP26-05-2020
26-05-2020
INDOCO REMEDIES LTD. - 532612 - Certificate Under Regulation 40(9) & (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under Regulation 40(9) & (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the six month period ended March 31, 2020.30-04-2020
INDOCO REMEDIES LTD. - 532612 - Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 For The Period Ended 31St March 2020
Compliance Certificate - Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 for the period ended 31st March 202021-04-2020
INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jayshankar MenonDesignation :- Company Secretary and Compliance Officer15-04-2020
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended March 31, 2020
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here13-04-2020
Indoco Remedies surges 16% as it ships Paracetamol tablets to UK
The permission granted by the Indian Government is for a total air shipment of 4.48 crore tablets.13-04-2020
INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of LODR Regulations 2015
This is to inform you that, Indoco has been part of the great initiative by the Indian government to export Paracetamol tablets to the UK in its fight against Covid 19. The first shipment of 11.70 lakh Paracetamol tablets to the UK was airlifted on 12th April, 2020 from Goa airport. The permission granted by the Indian Government is for a total air shipment of 4.48 crore tablets. The remaining quantity is ready for shipment and will be airlifted depending on availability of flights.13-04-2020
INDOCO REMEDIES LTD. - 532612 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Indoco Remedies Ltd has submitted to BSE a copy of Clarification is enclosed.01-04-2020
INDOCO REMEDIES LTD. - 532612 - Clarification sought from Indoco Remedies Ltd
The Exchange has sought clarification from Indoco Remedies Ltd on 01st April, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.01-04-2020
INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
In terms of the Company's 'Code of Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window for purchase/sale of shares of the Company by the Designated persons shall remain closed from April 1, 2020.30-03-2020